Table 2 Anti-factor xa activity and ClotPro values for samples spiked with low molecular weight heparin.

From: Detection of enoxaparin and argatroban by use of the novel viscoelastic coagulometer ClotPro

 

Reference range

CON = 0

N = 12

CON = 0.25

N = 12

CON = 0.5

N = 12

CON = 0.75

N = 12

CON = 1

N = 12

r

Anti-factor Xa activity (IU.ml− 1)

< 0.1

< 0.1 (< 0.1-<0.1)

0.18 (0.15–0.18)

0.41 (0.38–0.43)

0.59 (0.54–0.62)

0.82 (0.74–0.84)

-

Clotting time (s)

48–77

61 ± 8

77 ± 17

112 ± 24

142 ± 36

172 ± 47

0.88 (95% CI 0.8–0.92;

p < 0.001)

Clot formation time (s)

 

63 ± 14

65 ± 16

68 ± 18

72 ± 18

75 ± 18

0.32 (95% CI 0.08–0.53;

p = 0.01)

Amplitude after 5 min (mm)

38–55

45.3 ± 4.9

45.2 ± 5.2

44.8 ± 5.1

44.2 ± 5.0

43.3 ± 5.2

-0.22 (95% CI -0.45-0.03;

p = 0.09)

Amplitude after 10 min (mm)

47–63

53.4 ± 4.5

53.3 ± 4.7

53.2 ± 4.6

52.6 ± 4.6

51.8 ± 4.7

-0.2 (95% CI -0.43-0.05;

p = 0.12)

Amplitude after 20 min (mm)

53–67

57.6 ± 4.2

57.2 ± 4.5

57.3 ± 4.2

56.9 ± 4.2

56.6 ± 4.1

-0.16 (95% CI -0.39-0.1;

p = 0.24)

Amplitude after 30 min (mm)

 

57.9 ± 4.2

57.0 ± 4.7

57.5 ± 4.1

57.0 ± 4.2

57.0 ± 3.9

-0.14 (95% CI -0.38-0.12;

p = 0.29)

Maximum clot firmness (mm)

54–68

58.3 ± 4.2

57.6 ± 4.4

58.0 ± 3.9

57.4 ± 3.9

57.4 ± 3.8

-0.15 (95% CI -0.39-0.11;

p = 0.27)

  1. Anti-factor Xa activity is given as a median and interquartile range [IQR]. All other variables are given as means and standard deviations (± SD).
  2. CON, targeted concentration; r: Pearson’s correlation coefficient for variable with anti-factor Xa activity.